Tibet Duo Rui Pharmaceutical Co.Ltd(301075)
Opinions of the board of supervisors on matters related to the ninth meeting of the first board of supervisors
According to the company law of the people’s Republic of China In accordance with the relevant provisions of the Shenzhen Stock Exchange GEM Listing Rules (revised in December 2020), Shenzhen Stock Exchange listed companies’ self regulatory guidelines No. 2 – standardized operation of GEM listed companies, Tibet Duo Rui Pharmaceutical Co.Ltd(301075) articles of association and Tibet Duo Rui Pharmaceutical Co.Ltd(301075) rules of procedure of the board of supervisors, all supervisors of the board of supervisors, on the basis of careful inspection and review of relevant documents and materials, agreed on Tibet Duo Rui Pharmaceutical Co.Ltd(301075) (hereinafter referred to as the “company”) The opinions of the board of supervisors on relevant matters at the ninth meeting of the first board of supervisors are as follows:
1、 Opinions of the board of supervisors on the 2021 annual report and its summary
The board of supervisors believes that the preparation procedure, contents and format of the company’s annual report 2021 and its summary comply with the provisions of relevant documents; The contents of the report truly, accurately and completely reflect the actual situation of the company, and there are no false records, misleading statements or major omissions. This matter still needs to be submitted to the general meeting of shareholders of the company for deliberation.
2、 According to the opinions of the board of supervisors on the special report on the annual storage and use of raised funds, the board of supervisors believes that the company stores and uses the funds raised by IPO in strict accordance with relevant laws, regulations, normative documents and the relevant provisions of the company’s raised funds management system, which is in line with the relevant provisions of the CSRC and Shenzhen Stock Exchange on the storage and use of raised funds of listed companies, There is no situation of changing the investment direction of the raised funds in a disguised form and damaging the interests of shareholders. The special report of the board of directors on the annual storage and use of raised funds truthfully, accurately and completely disclosed the storage and use of the company’s raised funds, and the company faithfully fulfilled its obligation to disclose the investment direction and progress of the raised funds. This matter still needs to be submitted to the general meeting of shareholders of the company for deliberation.
3、 Self evaluation opinions of the board of supervisors 2021
The board of supervisors believes that the self-evaluation report on internal control in 2021 objectively and truly reflects the implementation of the company’s internal control in 2021, and believes that the company has no major defects in internal control over financial reporting, and no major defects in internal control over non-financial reporting have been found.
4、 Opinions of the board of supervisors on the proposal on the confirmation of regular connected transactions in 2021 and the proposal on the confirmation of connected guarantees in 2021
The board of supervisors believes that the related party transactions confirmed by the company in 2021 meet the requirements of Shenzhen Stock Exchange GEM Listing Rules (revised in December 2020), the articles of association and other relevant laws, regulations and normative documents. There were no cases that damaged the legitimate rights and interests of the company and minority shareholders, and the necessary review procedures were performed in strict accordance with relevant laws and regulations. Therefore, we unanimously agree on the matters related to the confirmation of related party transactions. This matter still needs to be submitted to the general meeting of shareholders of the company for deliberation.
(no text below)
(there is no text on this page, which is the signature page of Tibet Duo Rui Pharmaceutical Co.Ltd(301075) the opinions of the board of supervisors on matters related to the ninth meeting of the first board of supervisors) supervisor: Zhao Hongwei
Wang Tang
Zhou Jiali
March 24, 2022
